|
Case report | Lowest Na+ level, mmol/L | Normal plasma Na+ after, h | Est. fluid absorption, L | Irrigation fluid used | Max. fluid pressure, mmHg | Surgery time, min | Treatment for hyponatremia | First clinical manifestation | Presence of pulmonary edema | Type of anesthesia | Discharge day |
|
Okazaki et al. [31] | 84.1 | 15 | 7 | 3% d-sorbitol solution | N/A | 123 | Furosemide; 1.5% saline; acetate Ringer | Edemas in the conjunctiva, lip, and fingers | Yes | GA | 6 |
|
Palanisamy et al. [32] | 125 | N/A | N/A | 1.5% glycine | 100 | 120 | Furosemide | Abdominal distension and facial puffiness | No | GA | N/A |
|
Liao et al. [33] | 125 | 3 | N/A | 5% dextrose water | N/A | N/A | Sodium bicarbonate, 3% NaCl; mannitol; furosemide | Postoperative cardiac arrest | Yes | GA | 28 |
|
Elegante et al. [34] | 125 | 6 | 2.7 | 1.5% glycine | N/A | 30 | Furosemide | Hypoxia; dyspnea and altered mental status | Yes | N/A | Day 2 |
|
Chauha et al. [35] | 111 | 6 | N/A | 1.5% glycine | 90 | 120 | Furosemide | Swelling of the face and vision problem | No | GA | Day 1 |
|
Sultan [36] | 119 | 3 | 1.2 | 1.5% glycine | 100 | 65 | Furosemide | Confusion | No | Spinal anesthesia | Day 2 |
|
Hepp et al. [37] | 74 | 7 | 5 | 2.7% sorbitol and 0.54% mannitol | 120 | 70 | 3% NaCl; furosemide | Dyspnea | Yes | GA | Day 3 |
|
Almonti et al. [38] | 120 | 10 | 2 | 1.5% glycine | N/A | 60 | 7% NaCl; furosemide; mannitol | Myoclonus | No | GA | Day 2 |
|
Yaprak et al. [9] | 99 | 14 | 5 | Mannitol 5% | N/A | N/A | 3% NaCl; furosemide | Altered mental status and agitation | No | N/A | Day 2 |
|
Sethi et al. [7] | 100 | N/A | 1 | 1.5% glycine | 80 | 45 | 3% NaCl; furosemide; sodium bicarbonate | Hypoxia | Yes | GA | Day 14 |
|
Yang and Feng [10] | 120 | 12 | 3 | Dextrose 5% | 150 | 70 | 3% NaCl; furosemide | Flatulence and coma | No | N/A | N/A |
|
Woo et al. [8] | 87 | 48 | 24 | 2.7% sorbitol and 0.54% mannitol | 150 | 60 | 3% NaCl; furosemide | Dyspnea | Yes | GA | Day 7 |
|
Wegmuller et al. [39] | 78 | 36 | N/A | 2.7% sorbitol and 0.54% mannitol | 100 | 80 | Furosemide; hypertonic NaCl; bicarbonate 8.4% | Desaturation and laryngeal edema | Yes | Spinal anesthesia | Day 30 |
|
Jo et al. [5] | 83 | 24 | N/A | 5:1 sorbitol/mannitol | 120 | 150 | Furosemide; 3% NaCl | Hypoxia | Yes | GA | Day 4 |
|
Serocki et al. [40] | 106 | 24 | 0.4 L–4 | 2.7% sorbitol and 0.54% mannitol | 180 | 25 | 0.9% NaCl | Hypoxia | Yes | GA | Day 2 |
|
Lee et al. [41] | 89 | 24 | 7 | 2.7% sorbitol and 0.54% mannitol | 100 | 40 | 2% NaCl; sodium bicarbonate; furosemide; | Hypotonia and bleeding leading to hysterectomy | No | GA | Day 2 |
|
Estes and Maye [42] | 122 | 8 | 2.4 | 1.5% glycine | N/A | 90 | Furosemide | N/A | No | GA | Day 1 |
|
Arieff and Ayus [43] | 137 | N/A | N/A | 3% sorbitol and 1.5% glycine | N/A | 156 ± 24 | Hypertonic (514 mmol/L) sodium chloride | Tremulousness, hypothermia, hypoxia, postoperative: Headache, nausea, emesis, and seizures | No | GA | N/A |
|